Sensus Healthcare director buys 2,500 SRTS shares at $4.50
Sensus Healthcare, Inc. (SRTS) reported an insider share purchase by a director.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Sensus Healthcare, Inc. (SRTS) reported an insider share purchase by a director. On 11/13/2025, the reporting person bought 2,500 shares of common stock in an open market transaction coded "P" at a price of $4.50 per share. After this transaction, the director beneficially owns 133,113 shares of Sensus Healthcare common stock, held directly. This filing reflects a change in insider ownership rather than an operating or financial update for the company.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 2,500 | $4.50 | $11K |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction was reported for Sensus Healthcare (SRTS)?
What is the relationship of the reporting person to Sensus Healthcare (SRTS)?
Does this SRTS Form 4 involve derivative securities like options or warrants?
Is this Sensus Healthcare (SRTS) Form 4 filed for one or multiple reporting persons?
AI-generated analysis. How Rhea-AI works. Not financial advice.